218 related articles for article (PubMed ID: 29332907)
21. Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.
Wang Y; Gao W; Han X; Jiang J; Sandler B; Li X; Zema C
J Med Econ; 2023; 26(1):1495-1506. PubMed ID: 37902966
[TBL] [Abstract][Full Text] [Related]
22. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration.
Kofflard MJ; Ten Cate FJ; van der Lee C; van Domburg RT
J Am Coll Cardiol; 2003 Mar; 41(6):987-93. PubMed ID: 12651046
[TBL] [Abstract][Full Text] [Related]
23. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.
Autore C; Bernabò P; Barillà CS; Bruzzi P; Spirito P
J Am Coll Cardiol; 2005 Apr; 45(7):1076-80. PubMed ID: 15808767
[TBL] [Abstract][Full Text] [Related]
24. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
[TBL] [Abstract][Full Text] [Related]
25. Results from the Kochi RYOMA Study. Atrial fibrillation is a major risk of morbidity in patients with hypertrophic cardiomyopathy.
Ohe T
Circ J; 2009 Sep; 73(9):1589-90. PubMed ID: 19706983
[No Abstract] [Full Text] [Related]
26. Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
Abou Alaiwi S; Roston TM; Marstrand P; Claggett BL; Parikh VN; Helms AS; Ingles J; Lampert R; Lakdawala NK; Michels M; Owens AT; Rossano JW; Saberi S; Abrams DJ; Ashley EA; Semsarian C; Stendahl JC; Ware JS; Miller E; Ryan TD; Russell MW; Day SM; Olivotto I; Vissing CR; Ho CY
Circulation; 2023 Aug; 148(5):394-404. PubMed ID: 37226762
[TBL] [Abstract][Full Text] [Related]
27. E/e' ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction.
Lu DY; Haileselassie B; Ventoulis I; Liu HY; Liang HY; Pozios I; Canepa M; Phillip S; Abraham MR; Abraham T
Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):101-107. PubMed ID: 28977350
[TBL] [Abstract][Full Text] [Related]
28. Prognostic determinants of hypertrophic cardiomyopathy--the results of the Shiga Cardiomyopathy Study.
Yoshida M; Nakamura Y; Fukuhara T; Higashikawa M; Okada M; Shichiri G; Kinoshita M
Jpn Circ J; 1995 Nov; 59(11):745-53. PubMed ID: 8747764
[TBL] [Abstract][Full Text] [Related]
29. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
[TBL] [Abstract][Full Text] [Related]
30. [Long term follow-up results of 199 patients with hypertrophic cardiomyopathy].
Li M; Wang QB; Cheng K
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):988-91. PubMed ID: 18269816
[TBL] [Abstract][Full Text] [Related]
31. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
Rowin EJ; Maron BJ; Haas TS; Garberich RF; Wang W; Link MS; Maron MS
J Am Coll Cardiol; 2017 Feb; 69(7):761-773. PubMed ID: 28209216
[TBL] [Abstract][Full Text] [Related]
32. Obstructive sleep apnea and hypertrophic cardiomyopathy: a common and potential harmful combination.
Nerbass FB; Pedrosa RP; Danzi-Soares NJ; Drager LF; Arteaga-Fernández E; Lorenzi-Filho G
Sleep Med Rev; 2013 Jun; 17(3):201-6. PubMed ID: 23046848
[TBL] [Abstract][Full Text] [Related]
33. Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY).
Hourqueig M; Bouzille G; Mirabel M; Huttin O; Damy T; Labombarda F; Eicher JC; Charron P; Habib G; Réant P; Hagège A; Donal E;
Clin Res Cardiol; 2022 Feb; 111(2):163-174. PubMed ID: 34043053
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome in patients with apical hypertrophic cardiomyopathy.
Eriksson MJ; Sonnenberg B; Woo A; Rakowski P; Parker TG; Wigle ED; Rakowski H
J Am Coll Cardiol; 2002 Feb; 39(4):638-45. PubMed ID: 11849863
[TBL] [Abstract][Full Text] [Related]
35. Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.
Doi Y; Kitaoka H
J Cardiol; 2001; 37 Suppl 1():133-8. PubMed ID: 11433817
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
[TBL] [Abstract][Full Text] [Related]
37. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.
Maron BJ; Olivotto I; Spirito P; Casey SA; Bellone P; Gohman TE; Graham KJ; Burton DA; Cecchi F
Circulation; 2000 Aug; 102(8):858-64. PubMed ID: 10952953
[TBL] [Abstract][Full Text] [Related]
39. Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort.
Anastasakis A; Theopistou A; Rigopoulos A; Kotsiopoulou C; Georgopoulos S; Fragakis K; Sevdalis E; Stefanadis C
Hellenic J Cardiol; 2013; 54(4):281-8. PubMed ID: 23912920
[TBL] [Abstract][Full Text] [Related]
40. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
